NCT06558084 2024-08-16
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Completed
Clinical Trials
10 trialsNCT05266300 2022-11-01
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
University of Southern Denmark
Completed
NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed
NCT02457039 2019-05-20
Acupuncture Prevents Chemobrain in Breast Cancer Patients
The University of Hong Kong
Phase NA Completed
NCT00296036 2017-03-16
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003600 2016-07-13
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003068 2013-01-31
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00245050 2011-12-30
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Case Comprehensive Cancer Center
Phase 3 Completed
NCT00028964 2011-02-23
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
University of California, San Francisco
Phase 1/2 Completed
NCT00003269 2011-01-10
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Scripps Health
Phase 2 Completed